Amifostine vs no otoprotective intervention: Tumour response with intra‐arterial platinum (good and partial remission)
Amifostine showed no clear difference in tumour response with intra‐arterial platinum (good and partial… compared with no otoprotective intervention (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Amifostine vs no otoprotective intervention Tumour response with intra‐arterial platinum (good and partial remission) · children with cancer treated with platinum‐based therapy Amifostine showed no clear difference in tumour response with intra‐arterial platinum (good and partial… compared with no otoprotective intervention (low certainty). Medical interventions for the prevention of platinum‐induced hearing loss in children with cancer (2019) · Cochrane Headline outcomes only | RR 1.6 [0.97, 2.63] | 1 study · 27 participants | Low |
Amifostine vs no otoprotective intervention Tumour response with intra‐arterial platinum (good and partial remission) · children with cancer treated with platinum‐based therapy Amifostine showed no clear difference in tumour response with intra‐arterial platinum (good and partial… compared with no otoprotective intervention (low certainty). Medical interventions for the prevention of platinum‐induced hearing loss in children with cancer (2016) · Cochrane Headline outcomes onlyearlier version CD009219.PUB4, superseded | RR 1.6 [0.97, 2.63] | 1 study · 27 participants | Low |
Amifostine vs no otoprotective intervention Tumour response with intra‐arterial platinum (good and partial remission) · children with cancer treated with platinum‐based therapy Amifostine showed no clear difference in tumour response with intra‐arterial platinum (good and partial… compared with no otoprotective intervention (low certainty). Medical interventions for the prevention of platinum‐induced hearing loss in children with cancer (2014) · Cochrane Headline outcomes onlyearlier version CD009219.PUB3, superseded | RR 1.6 [0.97, 2.63] | 1 study · 27 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Medical interventions for the prevention of platinum‐induced hearing loss in children with cancer 2019 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.